These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30730120)

  • 1. [Apparent thyrotoxicosis in a patient with multiple sclerosis: biochemical assay interference due to high dose biotin use].
    van den Berg R; Slim CL; Lutgers HL; de Heide LJM; Wolthuis A
    Ned Tijdschr Geneeskd; 2018 Feb; 162():. PubMed ID: 30730120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intake of high dose biotin: A cause of artificial hyperthyroidism].
    Bouillet B; Rouland A
    Rev Med Interne; 2020 Feb; 41(2):123-125. PubMed ID: 31813616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses.
    Barbesino G
    Thyroid; 2016 Jun; 26(6):860-3. PubMed ID: 27043844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thyroid and pregnancy].
    Barthel A; Keck C; Janssen OE; Bornstein SR; Benker G
    Dtsch Med Wochenschr; 2012 Feb; 137(5):171-4. PubMed ID: 22278684
    [No Abstract]   [Full Text] [Related]  

  • 5. Misdiagnosis of Graves' hyperthyroidism due to therapeutic biotin intervention.
    De Roeck Y; Philipse E; Twickler TB; Van Gaal L
    Acta Clin Belg; 2018 Oct; 73(5):372-376. PubMed ID: 29098964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best practices in mitigating the risk of biotin interference with laboratory testing.
    Bowen R; Benavides R; Colón-Franco JM; Katzman BM; Muthukumar A; Sadrzadeh H; Straseski J; Klause U; Tran N
    Clin Biochem; 2019 Dec; 74():1-11. PubMed ID: 31473202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotin induced biochemical hyperthyroidism: a case report and review of the literature.
    James A; Stalan J; Kuzhively J
    J Med Case Rep; 2023 Jun; 17(1):266. PubMed ID: 37370185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent biochemical thyrotoxicosis due to assay interference by high-dose biotin given for multiple sclerosis.
    Cusini C; Sassi L; De Paola G; Piantanida E
    J Endocrinol Invest; 2017 Aug; 40(8):889-890. PubMed ID: 28478548
    [No Abstract]   [Full Text] [Related]  

  • 10. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A caution regarding high-dose biotin therapy: misdiagnosis of hyperthyroidism in euthyroid patients.
    Trambas CM; Sikaris KA; Lu ZX
    Med J Aust; 2016 Aug; 205(4):192. PubMed ID: 27510354
    [No Abstract]   [Full Text] [Related]  

  • 12. Apparent Hyperthyroidism Caused by Biotin-Like Interference from IgM Anti-Streptavidin Antibodies.
    Lam L; Bagg W; Smith G; Chiu WW; Middleditch MJ; Lim JC; Kyle CV
    Thyroid; 2018 Aug; 28(8):1063-1067. PubMed ID: 29808739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthyroidism.
    Nayak B; Hodak SP
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):617-56, v. PubMed ID: 17673122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
    Izumi Y; Takeoka K; Amino N
    Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients with Graves' disease.
    Kubota S; Takata K; Arishima T; Ohye H; Nishihara E; Kudo T; Ito M; Fukata S; Amino N; Miyauchi A
    Thyroid; 2008 Jan; 18(1):63-6. PubMed ID: 18302519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol.
    Nachum Z; Rakover Y; Weiner E; Shalev E
    Am J Obstet Gynecol; 2003 Jul; 189(1):159-65. PubMed ID: 12861156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated free thyroxine and free triiodothyronine probably caused by high-dose biotin intake in a patient with Graves' disease: a case report.
    Shimmaru K; Inami M; Hamaoka A; Fujiwara N; Morioka T; Emoto M; Kamei N
    Endocr J; 2023 Aug; 70(8):833-837. PubMed ID: 37331797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory tests for evaluating thyroid therapy.
    Kabadi UM
    Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperthyroidism.
    De Leo S; Lee SY; Braverman LE
    Lancet; 2016 Aug; 388(10047):906-918. PubMed ID: 27038492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.